Drug
N Acetylgalactosamine 4 Sulfatase
N Acetylgalactosamine 4 Sulfatase: highest development phase Phase 2, developed by BioMarin Pharmaceutical. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- BioMarin Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| N-acetylgalactosamine 4-sulfatase NCT00048711 | Phase 2 | Mucopolysaccharidosis VI |
Latest
No recent events.
Follow N Acetylgalactosamine 4 Sulfatase on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.